Clinical trial
Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma
NCT00116441 · Cell Genesys, Industry · Completed
Key facts
| NCT number | NCT00116441 |
|---|---|
| Title | Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma |
| Official title | Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma: The Use of Autologous Tumor Cells With an Allogeneic GM-CSF Producing Cell Line |
| Lead sponsor | Cell Genesys, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Biological |
| Interventions | Therapeutic Cellular Vaccine, GM-CSF Producing |
| Enrollment | 22 |
| Start date | Oct 1, 2000 |
| Completion | Oct 1, 2004 |
| First posted | Jun 30, 2005 |
| Last update posted | Dec 24, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: